Search
Products
Community
Markets
News
Brokers
More
IN
Get started
Jul 30, 2020
PumaPay (PMA) Looking Good, New Milestone Hit (1350% Mapped)
3
4
Grab this chart
Grab this chart
17
17
Let's start with the weekly chart for PumaPay (PMABTC).
We can see prices above EMA10.
3 satoshis hit for the first time since March.
MACD now on the bullish zone.
Very long accumulation phase coming to an end.
Very strong RSI.
These are bullish signals.
Over 1350% of potential growth mapped on the following chart:
(You can find additional targets if you zoom out the chart).
When we look at PMABTC daily, we can see that 3 satoshis is matching EMA300.
Prices are now sitting above EMA200 and MA200, as well as EMA10/50/100.
The MACD and RSI are both bullish... There aren't many sellers left that's for sure.
We will see how this one goes.
Thanks a lot for reading.
Namaste.
MasterAnanda
Follow
💥💥💥 Gain LIFETIME access for a one-time-payment —Lowest prices ever! 👉
lamatrades.com
(Since 2017)
Results:
🥇XRP +2010%
🥇ADA +2216%
🥇TOSHI +1642%
🥇AVA +536%
t.me/anandatrades/971
🏆 More:
t.me/alansantana1111/5935
Also on:
alanmasters
altcoins
Beyond Technical Analysis
bittrex
crypto
Cryptocurrency
Technical Indicators
okex
PMA
PMABTC
pumapay
Trend Analysis
MasterAnanda
Follow
💥💥💥 Gain LIFETIME access for a one-time-payment —Lowest prices ever! 👉
lamatrades.com
(Since 2017)
Results:
🥇XRP +2010%
🥇ADA +2216%
🥇TOSHI +1642%
🥇AVA +536%
t.me/anandatrades/971
🏆 More:
t.me/alansantana1111/5935
Also on:
Related publications
Bitcoin Continues Strong | Bull Aims At $13,500 or Higher
by MasterAnanda
Gold Hits A New All-Time High... $2461 Next Target!
by MasterAnanda
LBRY Credits (LBC) Now Above EMA300, Next Target Mapped
by MasterAnanda
Vanywhere (VANY) Project Overview + Analysis
by MasterAnanda
Bitcoin Straight Up? Short-Term 1H With Targets
by MasterAnanda
Crowd Machine (CMCT) Next Target
by MasterAnanda
Litecoin (LTC) Is On The Move
by MasterAnanda
Ripple (XRP) Weekly | 200% Growth Potential Mapped
by MasterAnanda
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the
Terms of Use
.